Search

Start Over Authors Rind, David M., author

2. Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease: effectiveness and value

Author(s):
Bradt, Pamela, author
Synnott, Patricia G., author
Chapman, Rick M., author
Beinfeld, Molly, author
Rind, David M., author
Pearson, Steven D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 12, 2020
Subject(s):
Anemia, Sickle Cell -- drug therapy
Antibodies, Monoclonal -- therapeutic use
Glutamine -- therapeutic use
Hemoglobin, Sickle -- antagonists & inhibitors
United States

3. Supervised injection facilities and other supervised consumption sites: effectiveness and value : final report

Author(s):
Armbrecht, Eric, author
Guzauskas, Greg, author
Hansen, Ryan, author
Pandey, Rajshree, author
Fazioli, Katherine, author
Chapman, Rick M., author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, January 8, 2021
Subject(s):
Harm Reduction
Needle-Exchange Programs
Opiate Overdose -- prevention & control
Opioid-Related Disorders -- therapy
United States

4. Nadofaragene firadenovec and oportuzumab monatox for BCG-unresponsive, non-muscle invasive bladder cancer: effectiveness and value : final report

Author(s):
Atlas, Steven J., author
Touchette, Daniel R., author
Beinfeld, Molly, author
McKenna, Avery, author
Joshi, Mrinmayee, author
Chapman, Rick M., author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, January 15, 2021
Subject(s):
Antibodies, Monoclonal -- therapeutic use
Urinary Bladder Neoplasms -- drug therapy
Genetic Vectors -- therapeutic use
United States

6. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value : final evidence report

Author(s):
Atlas, Steven J., author
Fox, Grace E., author
Agboola, Foluso, author
Campbell, Jonathan D., author
Pearson, Steven D., author
Rind, David M., author
Brouwer, Elizabeth, author
Carlson, Josh, author
Chen, Yilin, (Of University of Washington), author
Hansen, Ryan N., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 27, 2023
Subject(s):
Antibodies, Monoclonal -- therapeutic use
Dermatitis, Atopic
Janus Kinase Inhibitors -- therapeutic use
United States

7. Fezolinetant for moderate to severe vasomotor symptoms associated with menopause: effectiveness and value : final evidence report

Author(s):
Beaudoin, Francesca L., author
Wright, Abigail, (Of Institute for Clinical and Economic Review), author
Yeung, Kai, 1981- author
Moradi, Ashton, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Rind, David M., author
Lin, Grace A., author
McQueen, R. Brett, author
Gutierrez, Eric, (Of School of Pharmacy, University of Colorado), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, January 23, 2023
Subject(s):
Cost-Effectiveness Analysis
Heterocyclic Compounds, 2-Ring
Hot Flashes
Menopause
Thiadiazoles
Vasomotor System
United States

10. Resmetirom and obeticholic acid for non-alcoholic steatohepatitis (NASH): final evidence report

Author(s):
Tice, Jeffrey A., author
Fahim, Shahariar Mohammed, author
Richardson, Marina, author
Herce-Hagiwara, Belen, author
Chu, Janet N., author
Pearson, Steven D., author
Rind, David M., author
Suh, Kangho, author
Carlson, Josh, author
Dickerson, Ronald, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, May 25, 2023
Subject(s):
Chenodeoxycholic Acid -- analogs & derivatives
Liver Cirrhosis -- drug therapy
Non-alcoholic Fatty Liver Disease -- drug therapy
Pyridazines
Uracil -- analogs & derivatives
United States